Wednesday, August 03, 2016 1:04:49 AM
Hi Afford!
I remain fully invested in NWBO.
I think the long-term promise of this investment is huge, if it works it will help move cancer treatments away from chemo/radiation. But the risks are high if L fails we likely go much lower and possibly bust. But I think it's a risk worth taking going by promising pre-clinical and clinical results together with the early acceptance by Eu medical bodies, and to be confirmed Big Pharma collaborations.
So far NWBO is my worst performing holding but that can quickly change with a favorable L resolution. I am not sure about the timing for the resolution but I certainly wasn't expecting it to take over 11 months.
I remain fully invested in NWBO.
I think the long-term promise of this investment is huge, if it works it will help move cancer treatments away from chemo/radiation. But the risks are high if L fails we likely go much lower and possibly bust. But I think it's a risk worth taking going by promising pre-clinical and clinical results together with the early acceptance by Eu medical bodies, and to be confirmed Big Pharma collaborations.
So far NWBO is my worst performing holding but that can quickly change with a favorable L resolution. I am not sure about the timing for the resolution but I certainly wasn't expecting it to take over 11 months.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
